Clinical trial Recruiting at 3 sites Observational Ages 18 and up

Seismocardiography to gauge fitness and predict outcomes before esophageal cancer surgery

Official title: Evaluation of Seismocardiography (SCG) as a Tool for Assessing Fitness and Predicting Outcomes in Oesophageal Cancer Surgery

Run by Guy's and St Thomas' NHS Foundation Trust · NCT07159711 · Data updated 2026-11-12

A noninvasive seismocardiography device is tested to see if it can quickly estimate a patient’s fitness and help predict surgical outcomes for adults with esophageal cancer who are planning curative treatment.

More Prehabilitation trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment164 (estimated)
SponsorGuy's and St Thomas' NHS Foundation Trust
Academic / other
Drugs / interventionschemotherapy
Locations4 sites (Guildford and 3 other locations)
StatusRecruiting
StartedOctober 1, 2025
Main results expectedJune 1, 2027
Study endsDecember 2027
Registry record updatedSeptember 14, 2026
Trial IDNCT07159711 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) with esophageal cancer considered for curative treatment involving neoadjuvant therapy and esophageal resection.

Probably not a fit

Patients not undergoing planned curative resection or those with implanted cardiac devices may not benefit from Seismofit assessments.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study evaluates the Seismofit device, worn while the patient is lying down, as a rapid alternative to CPET for estimating cardiorespiratory fitness in adults with esophageal cancer. The goal is to see whether Seismofit-derived fitness correlates with postoperative complications after neoadjuvant therapy and esophagectomy or esophagogastrectomy. The study leverages data from patients undergoing curative-intent treatment across several UK centers, with standard CPET measurements used for comparison where available. If successful, Seismofit could streamline baseline fitness assessment and aid patient selection and prehabilitation planning. The trial explicitly excludes patients with implanted cardiac devices or those not proceeding to resection after multidisciplinary review.

Why it matters

Potential benefit: If successful, Seismofit could allow faster, simpler fitness screening to tailor prehabilitation and reduce surgical risk.

How similar studies have gone: Previous CPET-based assessments show fitness predicts postoperative risk; this device represents a novel application in this cancer setting with limited prior large-scale testing.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age \>=18
* Diagnosis of Oesophageal cancer (T0-4 N0-3 M0, Oesophageal / Gastro-Oesophageal Junction (GOJ) type 1-2 adenocarcinoma
* Patients being considered for curative treatment (i.e. due to undergo NAC and Oesophagectomy / Oesophago-Gastrectomy \[open / MIO / hybrid / robotic\])
* Patients able to give informed consent

Exclusion Criteria:

* Pregnant patients.
* Patients under the age of 18.
* Patients undergoing primary Oesophagectomy +/- Oesophago-Gastrectomy with no neoadjuvant therapy.
* Patients undergoing Neoadjuvant chemoradiotherapy.
* Patient's being treated with curative intent for Oesophageal Squamous cell carcinoma
* Patients that are deemed not fit or suitable for Oesophagogastric cancer resection as part of a Multi-Disciplinary Team meeting decision.
* Patients with implanted devices such as pacemakers or cardioverter-defibrillators.

Where it's running

  • Guy's and St Thomas' Hospital NHS Foundation Trust
    London, United Kingdom
    Recruiting
  • Royal Marsden NHS Foundation Trust
    London, United Kingdom
    Recruiting
  • University Hospital Southampton
    Southampton, United Kingdom
    Recruiting
  • Royal Surrey NHS Foundation Trust
    Guildford, United Kingdom
    Active not recruiting

Study contacts

  • Principal investigator: Andrew Davies, MD FRCS — Guy's and St Thomas NHS Foundation Trust
  • Study coordinator: Kesav Aditya Vijayagopal, DMS
  • Email: kesav.vijayagopal1@nhs.net
  • Phone: +447706649746

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.